Business Wire

Envoy Gateway Makes Using Envoy Proxy Easier for Developers and Reverses Fragmentation

16.5.2022 07:01:00 EEST | Business Wire | Press release

Share

Members of the steering group for Envoy Gateway (EG), including Envoy creator Matt Klein and representatives from Ambassador Labs, Fidelity Investments, Tetrate, and VMware, Inc., today announced their joint commitment to the project, which launched today at KubeCon + CloudNativeCon, Europe 2022, under the auspices of the Cloud Native Computing Foundation® (CNCF®). Envoy Gateway is a new effort within the Envoy proxy open source project to simplify Envoy use in cloud-native application development.

Envoy Gateway will reduce existing, redundant efforts around Envoy and make it much easier for application developers to use Envoy as a basic API gateway “out of the box” and as a Kubernetes Ingress controller. Exposing a simplified set of APIs, and implementing the Kubernetes Gateway API, EG makes it easier to extend Envoy. Developers will now have a cost-free, unfettered way to provide external access to their work in progress. At the same time, Envoy Gateway will not replace API management features currently found in commercial products.

“Envoy has achieved a great deal of success since we first released it in 2016,” said Matt Klein, founder of the Envoy proxy project. “And community has been at the heart of Envoy from the beginning. With the community-driven Envoy Gateway project, we see the opportunity to make Envoy accessible to many more users through the addition of simplified APIs and new capabilities explicitly targeted at north-south / edge proxy use cases.”

Envoy is already widely used for traffic between separate services in a microservices application—that is, east-west traffic. With Envoy Gateway, Envoy will also be easy to use for north-south traffic—traffic between an application and the outside world, as with consumers of an application’s APIs.

Envoy Gateway—Extensible Open Source Infrastructure for the Cloud-Native Future

IT organizations worldwide want to establish and use a rich, robust, modern stack of open source software for cloud-native application development and delivery, under the management of organizations such as the Linux Foundation and CNCF. Commercial offerings and projects within each IT team can then add value on top of this core infrastructure.

Envoy is fast becoming the go-to networking substrate within this modern, cloud-native stack. However, the need for API access, traffic routing, and other ingress capabilities has recently led to fragmentation in the Envoy ecosystem. Envoy Gateway will bring this needed functionality back into the main Envoy project and make it less confusing and time-consuming for developers to access Envoy.

Implementation Via Kubernetes Gateway API

Envoy Gateway will expose a version of the Kubernetes-native Gateway API, with Envoy-specific extensions. This is an expressive, extensible, role-oriented API well-suited to use by developers. Gateway API is either implemented, or in progress, for Istio, the Contour project (which originated at VMware), Emissary-ingress (which originated at Ambassador Labs), and others.

When users create Gateway API resources, they will be translated into native Envoy API calls, so Envoy and xDS, its native API, will not need to be changed to add this new support.

Advantages for Developers, Infrastructure Administrators and Business Decision-Makers

Application developers will experience the most positive impact from Envoy Gateway. They will be able to run Envoy Gateway and begin routing traffic to their applications. They will no longer need to build their own control plane, or extend an existing control plane such as a Go or Java control plane, or bring in a vendor solution at the early stages of their projects. They can just configure routes for the application and share them.

Infrastructure administrators will be able to easily offer an Envoy-native experience to application teams, without needing to adopt a vendor solution just to get basic gateway functionality. They will be able to manage instances of Envoy Gateway without interfering with developer access to them. Envoy Gateway will allow them to deliver consistent application networking capabilities across heterogeneous environments.

Executives and decision-makers will have Envoy as a standard and, we expect, widely-used solution for API access and Kubernetes ingress. They will also benefit from faster and easier development and delivery of more secure and robust software and services.

Additional Resources

  • Explore CNCF announcements.
  • Review the official blog of the Envoy project.
  • Learn more about Envoy Gateway goals.

About Envoy

Originally created by Matt Klein and built at Lyft, Envoy is a high performance C++ distributed proxy designed for single services and applications, as well as a communication bus and “universal data plane” designed for large microservice “service mesh” architectures. Built on the learnings of solutions such as NGINX, HAProxy, hardware load balancers, and cloud load balancers, Envoy runs alongside every application and abstracts the network by providing common features in a platform-agnostic manner. When all service traffic in an infrastructure flows via an Envoy mesh, it becomes easy to visualize problem areas via consistent observability, tune overall performance, and add substrate features in a single place.

Contact Matt Klein at mattklein123@gmail.com.

About Ambassador Labs

Ambassador Labs, the cloud native developer experience leader, enables developers to code, test, ship, and run applications faster and easier than ever. Maker of top Cloud Native Computing Foundation (CNCF) open source projects, including Emissary-ingress and Telepresence, Ambassador Labs delivers a developer control plane for Kubernetes that integrates the development, deployment, and production infrastructure for developers and organizations worldwide including Microsoft, PTC, NVidia, and Ticketmaster. Ambassador Labs is backed by top investors including Insight Partners and Matrix Partners. Learn more and get started for free at www.getambassador.io.

Contact Lisa Williams of Ambassador Labs at lisawilliams@datawire.io.

About Fidelity Investments

Fidelity’s mission is to inspire better futures and deliver better outcomes for the customers and businesses we serve. With assets under administration of $11.3 trillion, including discretionary assets of $4.2 trillion as of March 31, 2022, we focus on meeting the unique needs of a diverse set of customers. Privately held for over 75 years, Fidelity employs more than 57,000 associates who are focused on the long-term success of our customers. For more information about Fidelity Investments, visit www.fidelity.com/about-fidelity/our-company.

Contact Kathleen Bentley of Fidelity Investments at kathleen.bentley@fmr.com.

About Tetrate

Started by Istio founders to reimagine application networking, Tetrate is an enterprise service mesh company managing the complexity of modern, hybrid cloud application infrastructure. Its flagship product, Tetrate Service Bridge, provides an edge-to-workload application connectivity platform to deliver business continuity, agility, and security for enterprises on the journey from traditional monoliths to the cloud. Customers get consistent, baked-in observability, runtime security and traffic management in any environment. Tetrate continues to serve as a top contributor to the open-source projects Istio and Envoy Proxy. Find out more at www.tetrate.io.

Contact Annie Fink of Bospar at annie@bospar.com.

About VMware

VMware is a leading provider of multi-cloud services for all apps, enabling digital innovation with enterprise control. As a trusted foundation to accelerate innovation, VMware software gives businesses the flexibility and choice they need to build the future. Headquartered in Palo Alto, California, VMware is committed to building a better future through the company’s 2030 Agenda. For more information, please visit www.vmware.com/company.

Contact Eloy Ontiveros of VMware Global Communications at eontiveros@vmware.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tetrate
Annie Fink of Bospar, annie@bospar.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye